COVID-19 curbs to end in Australian state, continue in Sydney
- New South Wales records 172 new cases, most since March 2020
- Victoria will ease curbs on Weds after 10 new cases
- NSW to decide soon whether to extend five-week lockdown
- South Australia to lift restrictions after no new cases
CANBERRA/SYDNEY, July 27 (Reuters) - Australia's Victoria state said on Tuesday it will end lockdown after curtailing the spread of COVID-19, but neighbouring New South Wales faced a four-week extension of restrictions according to media reports after new cases hit a 16-month peak.
More than half of Australia's near 26 million population has been in lockdown in recent weeks after an outbreak of the highly infectious Delta variant took hold in the New South Wales capital of Sydney and spread to three states.
New South Wales reported 172 COVID-19 cases in the past 24 hours, up from 145 a day earlier, with at least 60 spending time in the community while infectious.
New South Wales Premier Gladys Berejiklian said a decision whether to lift the five-week lockdown will be taken this week, and local media later reported the state would announce a four-week extension of the order on Wednesday. With less than 13% of the state's population fully vaccinated, curbs are expected to stay.
"We know we've put in the hard yards for five weeks and we don't want to waste all the good work that we've done by opening too early and then having the virus spread again," Berejiklian told a media conference.
A spokesperson was not immediately available to confirm the media reports about the planned lockdown extension.
In contrast, Victoria state said most restrictions imposed on July 15 will be removed from Wednesday after recording just 10 infections of people already in quarantine.
"All in all, this is a good day," Victoria state Premier Daniel Andrews told reporters in Melbourne.
Victoria's 5 million residents will be allowed to leave home freely and schools will reopen, though households will not be permitted to have visitors.
South Australia said it will also lift a lockdown on Wednesday after it recorded zero COVID-19 cases in the past 24 hours.
Lockdowns have raised the prospect of Australia recording its second recession in as many years, though Treasurer Josh Frydenberg said on Tuesday talk of this was premature.
Frydenberg said last week the country's A$2 trillion ($1.5 trillion) economy is expected to shrink in the latest GDP figures, with lockdowns costing about A$300 million daily.
Easing lockdowns will soften the economic toll, but New South Wales is Australia's biggest state economy and accounts for about a third of national output.
VACCINE ROLLOUT CRITICISED
Swift contact tracing, tough social distancing rules and lockdowns have helped Australia to keep its COVID-19 numbers low, with just under 33,100 cases and 920 deaths since the pandemic first appeared in early 2020.
The outbreak in Sydney, however, has seen a wave of hospitalisations and 10 deaths in recent weeks.
New South Wales said 169 people are in hospital with the virus, of which 46 are in intensive care.
Amid heightened concerns about hospitalisations of younger people, Australia has urged people to take AstraZeneca's (AZN.L) COVID-19 vaccine after struggling to secure enough supplies of Pfizer's (PFE.N) inoculations.
Authorities had previously recommended only over 60s should take the AstraZeneca shot after rare but serious blood clotting cases.
Former Prime Minister Malcolm Turnbull told the BBC Australia's vaccine rollout has been "a colossal failure" because the government failed to buy enough vaccines. read more
"It's the biggest failure of public administration I can recall," Turnbull said.
Faced with being unable to secure a Pfizer vaccine until at least September, tens of thousands of people have opted to receive the AstraZeneca vaccine - though many others have said they will wait.
"I'm kind of opposed to getting AstraZeneca due to the information that was provided earlier about the blood clots," said Rebecca Carlisle, who works in human resources in Sydney.
"I'm not willing to get AstraZeneca."
($1 = 1.3552 Australian dollars)
Our Standards: The Thomson Reuters Trust Principles.